{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:08:42Z","timestamp":1793956122696,"version":"4.8.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012602","name":"Startup Foundation for Hundred-Talent Program of Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013807","name":"Wuhan University School of Medicine","doi-asserted-by":"publisher","award":["32141004"],"award-info":[{"award-number":["32141004"]}],"id":[{"id":"10.13039\/501100013807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971528"],"award-info":[{"award-number":["81971528"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82225022"],"award-info":[{"award-number":["82225022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M692779"],"award-info":[{"award-number":["2021M692779"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M702852"],"award-info":[{"award-number":["2021M702852"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["82201926"],"award-info":[{"award-number":["82201926"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX2021259"],"award-info":[{"award-number":["BX2021259"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.immuni.2023.05.014","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T10:27:17Z","timestamp":1686652037000},"page":"1485-1501.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design"],"prefix":"10.1016","volume":"56","author":[{"given":"Yusha","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taijie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panfeng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2023.05.014_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2023.05.014_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","article-title":"IL-1 pathways in inflammation and human diseases","volume":"6","author":"Gabay","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.immuni.2023.05.014_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2023.05.014_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(88)90185-7","article-title":"Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis","volume":"332","author":"Eastgate","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2023.05.014_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2018.12.012","article-title":"Cell-type-specific interleukin 1 Receptor 1 signaling in the brain regulates distinct neuroimmune activities","volume":"50","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2023.05.014_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1742-2094-10-151","article-title":"Involvement of interleukin-1\u03b2 in the autophagic process of microglia: relevance to Alzheimer\u2019s disease","volume":"10","author":"Fran\u00e7ois","year":"2013","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.immuni.2023.05.014_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000255051","article-title":"Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment","volume":"28","author":"Forlenza","year":"2009","journal-title":"Dem. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.immuni.2023.05.014_bib8","first-page":"4771","article-title":"Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice","volume":"50","author":"Giavazzi","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2023.05.014_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1470-2045(14)70155-X","article-title":"MABp1, a first-in-class true human antibody targeting interleukin-1\u03b1 in refractory cancers: an open-label, phase 1 dose-escalation and expansion study","volume":"15","author":"Hong","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.immuni.2023.05.014_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.RES.81.4.493","article-title":"Interleukin-1\u03b2 inhibits phospholamban gene expression in cultured cardiomyocytes","volume":"81","author":"McTiernan","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.immuni.2023.05.014_bib11","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0735-1097(00)00526-X","article-title":"Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes","volume":"35","author":"Tatsumi","year":"2000","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.immuni.2023.05.014_bib12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/1078-0432.CCR-05-1603","article-title":"The role of interleukin 1 in growth and metastasis of human cancer xenografts","volume":"12","author":"Elaraj","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2023.05.014_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/343336a0","article-title":"Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor","volume":"343","author":"Hannum","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.05.014_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/343341a0","article-title":"Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist","volume":"343","author":"Eisenberg","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.05.014_bib15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/344633a0","article-title":"Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein","volume":"344","author":"Carter","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.05.014_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror Autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (\u2217)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2023.05.014_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41584-022-00797-1","article-title":"IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting","volume":"18","author":"Broderick","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.immuni.2023.05.014_bib18","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1\u2013receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib19","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus","volume":"360","author":"Reddy","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.191.2.313","article-title":"Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist\u2013deficient mice","volume":"191","author":"Horai","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib21","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.1035999100","article-title":"IL-17 production from activated T\u00a0cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist","volume":"100","author":"Nakae","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2023.05.014_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.0022-202X.2004.22305.x","article-title":"Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist","volume":"122","author":"Shepherd","year":"2004","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.immuni.2023.05.014_bib23","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","article-title":"Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist","volume":"364","author":"Hoffman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2023.05.014_bib24","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1\u03b2 inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib26","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.immuni.2023.05.014_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","article-title":"Rilonacept for colchicine-resistant or -Intolerant familial Mediterranean fever: a randomized trial","volume":"157","author":"Hashkes","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib28","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2023.05.014_bib29","first-page":"1","article-title":"Anakinra: interleukin-1 receptor antagonist therapy for rheumatoid arthritis","volume":"16","author":"Garces","year":"2001","journal-title":"Issues Emerging Health Technol."},{"key":"10.1016\/j.immuni.2023.05.014_bib30","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib31","doi-asserted-by":"crossref","first-page":"888392","DOI":"10.3389\/fimmu.2022.888392","article-title":"Systematic review of safety and efficacy of IL-1-targeted biologics in treating immune-mediated disorders","volume":"13","author":"Arnold","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2023.05.014_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm811","article-title":"Cytokine traps: multi-component, high-affinity blockers of cytokine action","volume":"9","author":"Economides","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94838","article-title":"Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist","volume":"2","author":"Garg","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2023.05.014_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis","volume":"384","author":"Klein","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib35","doi-asserted-by":"crossref","first-page":"25222","DOI":"10.1073\/pnas.1908576116","article-title":"Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus","volume":"116","author":"Mistry","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2023.05.014_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00281-013-0375-7","article-title":"Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity","volume":"35","author":"Carmona-Rivera","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.immuni.2023.05.014_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2023.05.014_bib38","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.immuni.2023.05.014_bib39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/386194a0","article-title":"A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist","volume":"386","author":"Schreuder","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.05.014_bib40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1165\/ajrcmb.10.5.8179914","article-title":"Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes","volume":"10","author":"Marsh","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.immuni.2023.05.014_bib41","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K","article-title":"IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1RA and IL-1beta genes","volume":"28","author":"Hurme","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2023.05.014_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S0016672310000704","article-title":"Identifying a major locus that regulates spontaneous arthritis in IL-1RA-deficient mice and analysis of potential candidates","volume":"93","author":"Jiao","year":"2011","journal-title":"Genet. Res. (Camb)"},{"key":"10.1016\/j.immuni.2023.05.014_bib43","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/nprot.2006.393","article-title":"Collagen antibody-induced arthritis","volume":"1","author":"Khachigian","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2023.05.014_bib44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2023.05.014_bib45","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.0803007","article-title":"The mechanism of osteoclast differentiation induced by IL-1","volume":"183","author":"Kim","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2023.05.014_bib46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2023.05.014_bib47","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.4049\/jimmunol.144.6.2216","article-title":"IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1","volume":"144","author":"Schindler","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2023.05.014_bib48","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1006\/cyto.1998.0369","article-title":"Molecular analysis of constitutive IL-1alpha gene expression in human melanoma cells: autocrine stimulation through NF-kappaB activation by endogenous IL-1alpha","volume":"10","author":"Kimura","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.immuni.2023.05.014_bib49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2012.08.003","article-title":"A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset","volume":"145","author":"Altiok","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.immuni.2023.05.014_bib50","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/rheumatology\/keaa119","article-title":"New variant in the IL1RN-gene (DIRA) associated with late-onset, CRMO-like presentation","volume":"59","author":"Kuemmerle-Deschner","year":"2020","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.immuni.2023.05.014_bib51","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1002\/art.30588","article-title":"A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil","volume":"63","author":"Jesus","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.immuni.2023.05.014_bib52","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.40498","article-title":"IL1RN variation influences both disease susceptibility and response to recombinant human interleukin-1 receptor antagonist therapy in systemic juvenile idiopathic arthritis","volume":"70","author":"Arthur","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.immuni.2023.05.014_bib53","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/ard.2009.113043","article-title":"Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations","volume":"69","author":"Attur","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2023.05.014_bib54","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/annrheumdis-2019-216055","article-title":"Interleukin 1 receptor antagonist (IL1RN) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease","volume":"79","author":"Attur","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2023.05.014_bib55","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.joca.2013.04.003","article-title":"IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort","volume":"21","author":"Wu","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.immuni.2023.05.014_bib56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1164\/rccm.201403-0586OC","article-title":"A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock","volume":"190","author":"Meyer","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib57","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/ATVBAHA.108.167437","article-title":"Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation","volume":"28","author":"Reiner","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.immuni.2023.05.014_bib58","doi-asserted-by":"crossref","first-page":"e1247","DOI":"10.1002\/mgg3.1247","article-title":"Genetic polymorphisms of IL1RN were associated with lumbar disk herniation risk in a Chinese Han population","volume":"8","author":"Tai","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib59","doi-asserted-by":"crossref","first-page":"332","DOI":"10.12965\/jer.140155","article-title":"Exonic polymorphism (rs315952, Ser133Ser) of interleukin 1 receptor antagonist (IL1RN) is related to overweigh\/obese with hypertension","volume":"10","author":"Yang","year":"2014","journal-title":"J.\u00a0Exer. Rehabil."},{"key":"10.1016\/j.immuni.2023.05.014_bib60","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/art.38873","article-title":"Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis","volume":"67","author":"Robinson","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.immuni.2023.05.014_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MIB.0000000000000584","article-title":"Identification of ten additional susceptibility loci for ulcerative colitis through immunochip analysis in koreans","volume":"22","author":"Ye","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.immuni.2023.05.014_bib62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2119\/molmed.2014.00097","article-title":"Immunochip identifies novel, and replicates known, genetic risk loci for rheumatoid arthritis in black South Africans","volume":"20","author":"Govind","year":"2014","journal-title":"Mol. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib63","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","article-title":"IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17","volume":"47","author":"Hashizume","year":"2008","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.immuni.2023.05.014_bib64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology","volume":"15","author":"Kwan Tat","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.immuni.2023.05.014_bib65","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fimmu.2019.00629","article-title":"The RANKL-RANK axis: a bone to thymus round trip","volume":"10","author":"Sobacchi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2023.05.014_bib66","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2015.08.010","article-title":"Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts","volume":"65","author":"Zhang","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.immuni.2023.05.014_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141008","article-title":"IL-1\u03b2\u2013driven osteoclastogenic Tregs accelerate bone erosion in arthritis","volume":"131","author":"Levescot","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2023.05.014_bib68","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1038\/ncomms8464","article-title":"IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+V\u03b36+\u03b3\u03b4 T\u00a0cells","volume":"6","author":"Akitsu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2023.05.014_bib69","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20742","article-title":"TNF-\u03b1 is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist\u2013deficient mice","volume":"114","author":"Horai","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2023.05.014_bib70","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib71","doi-asserted-by":"crossref","first-page":"108577","DOI":"10.1016\/j.intimp.2022.108577","article-title":"Role of interleukin-1 in the pathogenesis of colorectal cancer: A brief look at anakinra therapy","volume":"105","author":"Xie","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.immuni.2023.05.014_bib72","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1158\/0008-5472.CAN-18-2225","article-title":"An interleukin-1 signature in breast cancer treated with interleukin-1 receptor blockade: implications for treating cytokine release syndrome of checkpoint inhibitors","volume":"78","author":"Dinarello","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2023.05.014_bib73","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1158\/0008-5472.CAN-18-0413","article-title":"IL1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer","volume":"78","author":"Wu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2023.05.014_bib74","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-021-00305-w","article-title":"IL-1b drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer","volume":"7","author":"Tulotta","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.immuni.2023.05.014_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031731","article-title":"The therapeutic prospects of targeting IL-1R1 for the modulation of neuroinflammation in central nervous system disorders","volume":"23","author":"Lu\u00eds","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.immuni.2023.05.014_bib76","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1136\/annrheumdis-2017-211473","article-title":"A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean fever","volume":"76","author":"Moghaddas","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2023.05.014_bib77","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","article-title":"De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases","volume":"46","author":"Aksentijevich","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.immuni.2023.05.014_bib78","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2023.05.014_bib79","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2023.05.014_bib80","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.immuni.2023.05.014_bib81","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2023.05.014_bib82","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.1073\/pnas.1612594113","article-title":"Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease","volume":"113","author":"Zhou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2023.05.014_bib83","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","article-title":"A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1","volume":"577","author":"Tao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.05.014_bib84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/417091a","article-title":"Neutrophil elastase targets virulence factors of enterobacteria","volume":"417","author":"Weinrauch","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2023.05.014_bib85","doi-asserted-by":"crossref","first-page":"W382","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: an online force field","volume":"33","author":"Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761323002315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761323002315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:21:24Z","timestamp":1761034884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761323002315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1074761323002315"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2023.05.014","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2023.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}